Deep Track Capital, LP Acumen Pharmaceuticals, Inc. Transaction History

Deep Track Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$4.15 - $9.72 $5.82 Million - $13.6 Million	-1,403,317 Reduced 35.83%	2,513,044 $10.4 Million
Q2 2023 Aug 14, 2023	SELL	$3.59 - $6.59 $127,944 - $234,861	-35,639 Reduced 0.9%	3,916,361 $18.8 Million
Q4 2022 Feb 14, 2023	BUY	$4.81 - $10.17 $833,005 - $1.76 Million	173,182 Added 4.58%	3,952,000 $21.3 Million
Q3 2022 Nov 14, 2022	BUY	$4.44 - $10.48 $3.01 Million - $7.11 Million	678,818 Added 21.9%	3,778,818 $37.9 Million
Q2 2022 Aug 12, 2022	BUY	$3.08 - $4.88 $1.54 Million - $2.44 Million	500,902 Added 19.27%	3,100,000 $14.6 Million
Q1 2022 May 16, 2022	BUY	$3.91 - $6.73 $2.6 Million - $4.48 Million	666,058 Added 34.46%	2,599,098 $10.2 Million
Q4 2021 Feb 14, 2022	BUY	$6.54 - $15.31 $12.6 Million - $29.6 Million	1,933,040 New	1,933,040 $13.1 Million

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $59.9M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.